Financial News
Latest News about ROIV
Recent news which mentions ROIV
Earnings Scheduled For November 13, 2023
November 13, 2023
From Benzinga
From Motley Fool
FSR Stock Alert: What to Know as Fisker Drops Prices
October 23, 2023
From InvestorPlace
PINS Stock Pops as Stifel Upgrades Pinterest
October 23, 2023
From InvestorPlace
Why Is Roivant Sciences (ROIV) Stock Up Today?
October 23, 2023
From InvestorPlace
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal
October 23, 2023
From Benzinga
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
October 23, 2023
From MarketWatch
Why Troika Media Group Shares Are Trading Lower By Over 20%; Here Are 20 Stocks Moving Premarket
October 23, 2023
From Benzinga
Morgan Stanley’s Wilson: Next rally attempt will fail as investors are punishing earnings reports.
October 23, 2023
From MarketWatch
Textainer Group, Roivant Sciences And Other Big Stocks Moving Higher In Monday's Pre-Market Session
October 23, 2023
From Benzinga
Hess stock climbs on $53 billion Chevron deal and other movers
October 23, 2023
From MarketWatch
What 8 Analyst Ratings Have To Say About Roivant Sciences
October 17, 2023
Tickers
ROIV
From Benzinga
3 No-Brainer Growth Stocks to Buy in October
October 01, 2023
From Motley Fool
Why Immunovant Stock Is Bolting Higher Today
September 27, 2023
From Motley Fool
Johnson Controls International To Rally Over 27%? Here Are 10 Other Analyst Forecasts For Wednesday
September 27, 2023
From Benzinga
Why Shares of Immunovant Are Soaring on Tuesday
September 26, 2023
From Motley Fool
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
From Benzinga
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
From Benzinga
Why Is Autoimmune Disease-Focused Immunovant Stock Trading Higher Today?
September 26, 2023
From Benzinga
These 2 Biotech Stocks Are Bucking a Down Market Tuesday
September 26, 2023
From Motley Fool
Vivek Ramaswamy's Parallels With Warren Buffett Run Deeper Than Wanting To Make Roivant The 'Berkshire Hathaway Of Drug Development'
September 04, 2023
From Benzinga
What 9 Analyst Ratings Have To Say About Roivant Sciences
August 31, 2023
Tickers
ROIV
From Benzinga
2 Supercharged Growth Stocks Billionaires Can't Stop Buying
August 28, 2023
From Motley Fool
If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now
August 25, 2023
From Benzinga
Earnings Scheduled For August 14, 2023
August 14, 2023
From Benzinga
3 Biotech Stocks That Analysts Are Drooling Over
August 07, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
